584 related articles for article (PubMed ID: 20467795)
21. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Wendt MK; Allington TM; Schiemann WP
Future Oncol; 2009 Oct; 5(8):1145-68. PubMed ID: 19852727
[TBL] [Abstract][Full Text] [Related]
23. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
24. Role of TGF-β and the tumor microenvironment during mammary tumorigenesis.
Taylor MA; Lee YH; Schiemann WP
Gene Expr; 2011; 15(3):117-32. PubMed ID: 22268294
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-to-mesenchymal transitions and circulating tumor cells.
Bonnomet A; Brysse A; Tachsidis A; Waltham M; Thompson EW; Polette M; Gilles C
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):261-73. PubMed ID: 20449641
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
27. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
29. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.
Wendt MK; Tian M; Schiemann WP
Cell Tissue Res; 2012 Jan; 347(1):85-101. PubMed ID: 21691718
[TBL] [Abstract][Full Text] [Related]
30. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.
Turcatel G; Rubin N; El-Hashash A; Warburton D
PLoS One; 2012; 7(1):e31032. PubMed ID: 22299047
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
32. Mnt Represses Epithelial Identity To Promote Epithelial-to-Mesenchymal Transition.
Lavin DP; Abassi L; Inayatullah M; Tiwari VK
Mol Cell Biol; 2021 Oct; 41(11):e0018321. PubMed ID: 34460331
[TBL] [Abstract][Full Text] [Related]
33. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
Creighton CJ; Chang JC; Rosen JM
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
[TBL] [Abstract][Full Text] [Related]
35. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
36. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
[TBL] [Abstract][Full Text] [Related]
37. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
38. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
McCoy EL; Iwanaga R; Jedlicka P; Abbey NS; Chodosh LA; Heichman KA; Welm AL; Ford HL
J Clin Invest; 2009 Sep; 119(9):2663-77. PubMed ID: 19726883
[TBL] [Abstract][Full Text] [Related]
39. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
40. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]